Attenuation of contractility in rat epididymal vas deferens by Rho kinase inhibitors
- PMID: 16553645
- DOI: 10.1111/j.1474-8673.2006.00367.x
Attenuation of contractility in rat epididymal vas deferens by Rho kinase inhibitors
Abstract
The involvement of Ca(2+) sensitization mediated through Rho kinase in the contractility of rat epididymal vas deferens was investigated using Rho kinase inhibitors, trans-4-[(1R)-1-aminoethyl]-N-4-pyridinilcyclohexanecarboxamide dihydrochloride (Y-27632) and 1-(5-isoquinolinesulphonyl)homopiperazine (HA 1077), in comparison with myosin light chain kinase (MLCK) inhibitors, wortmannin and 1-(5-chloronaphthalenesulphonyl)homopiperazine (ML-9) and agents that affect protein kinase C (PKC) and non-receptor tyrosine kinase intracellular signalling. 2 In Ca(2+)-free/ethyleneglycol-bis-(beta-aminoethylether)N,N,N('),N(')-tetraacetic acid (EGTA) (1 mM) medium, noradrenaline evoked sustained contractions. Y-27632 and HA 1077 caused a concentration-dependent inhibition and complete relaxation (IC(50), 1.08 and 1.75 microM respectively). The Ca(2+)-free contraction was reduced by wortmannin (10 microM) or ML-9 (10 microM) but not by inhibitors of diacylglycerol metabolism, 3-[2-[4[bis(4-Fluoropheny)methylene]-1-piperidinyl]-2,3-dihydro-2-thioxi-4(H)-quinazolinone (R59949) (10 microm) or 1,6-bis(cyclohexyloximinocarbonylamino)hexane (RHC-80267) (10 microM) or by the phospholipase A(2) (PLA(2)) inhibitor, quinacrine (up to 100 microM) or tyrosine kinase inhibitor, genistein (30 microM). 3 In the presence of Ca(2+) (2.5 mM), noradrenaline (100 microM) evoked rhythmic activity and biphasic tonic contractions. Y-27632 (1-10 microM) or HA 1077 (1-10 microM) reduced the amplitude of rhythmic activity and tonic contractions. ML-9 (10 microM) attenuated the occurrence of rhythmic activity and modestly reduced the tonic contractions. ML-9 (10 microM) combined with Y-27632 (10 microM) significantly reduced the tonic contractions. ML-9 (30 microM) alone (or combined with Y-27632 10 microM) suppressed the rhythmic activity and substantially reduced (or abolished) the tonic contractions. 4 Contractions evoked by high [K(+)](o) (120 mM) or alpha,beta-methylene ATP (10 microM) were reduced significantly by Y-27632 (1-3 microM) indicating that the Rho kinase signalling pathway is activated by direct tissue depolarization or by stimulation of ligand-gated P(2X) purinoceptors. 5 Collectively, these results indicate that Ca(2+)-sensitization mediated by Rho kinase is involved in agonist- or depolarization-induced contraction of rat epididymal vas deferens. It is the major contractile mechanism underlying noradrenaline-induced Ca(2+)-free responses. It contributes to Ca(2+)-dependent rhythmic contractility and optimizes the development of full contractile tension triggered through calmodulin/MLCK activation by stimulated influx of Ca(2+).
Similar articles
-
Expression of Rho-kinase and its functional role in the contractile activity of the mouse vas deferens.Br J Pharmacol. 2003 Oct;140(4):743-9. doi: 10.1038/sj.bjp.0705479. Epub 2003 Sep 22. Br J Pharmacol. 2003. PMID: 14504141 Free PMC article.
-
Mechanisms underlying postjunctional synergism between responses of the vas deferens to noradrenaline and ATP.Eur J Pharmacol. 2004 Sep 13;498(1-3):241-8. doi: 10.1016/j.ejphar.2004.07.055. Eur J Pharmacol. 2004. PMID: 15364001
-
Rho kinase inhibitors reduce neurally evoked contraction of the rat tail artery in vitro.Br J Pharmacol. 2005 Nov;146(6):854-61. doi: 10.1038/sj.bjp.0706377. Br J Pharmacol. 2005. PMID: 16113686 Free PMC article.
-
[Involvement of small GTPase Rho and Rho-kinase in the pathogenesis of hypertension and hypertensive target organ damage].Nihon Rinsho. 2004 Mar;62 Suppl 3:202-6. Nihon Rinsho. 2004. PMID: 15171369 Review. Japanese. No abstract available.
-
The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine as a probing molecule for Rho-kinase-involved pathway.Pharmacol Ther. 2002 Feb-Mar;93(2-3):225-32. doi: 10.1016/s0163-7258(02)00191-2. Pharmacol Ther. 2002. PMID: 12191614 Review.
Cited by
-
Physiological and pharmacological aspects of the vas deferens-an update.Front Pharmacol. 2013 Aug 22;4:101. doi: 10.3389/fphar.2013.00101. eCollection 2013. Front Pharmacol. 2013. PMID: 23986701 Free PMC article.
-
Myosin light chain kinase is central to smooth muscle contraction and required for gastrointestinal motility in mice.Gastroenterology. 2008 Aug;135(2):610-20. doi: 10.1053/j.gastro.2008.05.032. Epub 2008 May 15. Gastroenterology. 2008. PMID: 18586037 Free PMC article.
-
Basal release of 6-cyanodopamine from rat isolated vas deferens and its role on the tissue contractility.Pflugers Arch. 2024 Aug;476(8):1263-1277. doi: 10.1007/s00424-024-02985-2. Epub 2024 Jul 4. Pflugers Arch. 2024. PMID: 38963545
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous